Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer
Clinical trial NCT02779855 · COMPLETED
Trial details
- NCT number
- NCT02779855
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-02
- Primary completion
- 2020-09-20
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.